%PDF-1.4
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
uuid:036efcfe-6952-9a4f-b3fa-f1e9f875eb56
adobe:docid:indd:3ed7192f-9d8a-11e5-bc04-d8395dce0b18
xmp.id:E97D7E1A18206811822AE0BC7581C7DF
proof:pdf
xmp.iid:1C7506E707206811822AAF32115AF2AA
adobe:docid:indd:3ed7192f-9d8a-11e5-bc04-d8395dce0b18
adobe:docid:indd:3ed7192f-9d8a-11e5-bc04-d8395dce0b18
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CS6 (Macintosh)
/
2017-12-18T10:59:37+08:00
2017-12-18T10:59:37+08:00
2017-12-18T10:59:37+08:00
2017-12-18T10:59:37+08:00
Adobe InDesign CS6 (Macintosh)
application/pdf
Adobe PDF Library 10.0.1
False
endstream
endobj
5 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[6.0 6.0 528.0 753.0]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[6.0 6.0 528.0 753.0]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/TrimBox[6.0 6.0 528.0 753.0]/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[6.0 6.0 528.0 753.0]/Type/Page>>
endobj
11 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[6.0 6.0 528.0 753.0]/Type/Page>>
endobj
27 0 obj
<>stream
BT
0 0 0 1 k
/GS0 gs
/T1_0 1 Tf
10 0 0 10 450 29.18 Tm
(255)Tj
ET
q
0 g
/GS1 gs
/Fm0 Do
Q
BT
/T1_0 1 Tf
0.005 Tc 0.064 Tw /Span<>> BDC
8.5 0 0 8.5 66 692.053 Tm
( )Tj
EMC
0.147 0 Td
(18.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(W)79.8(ang ZM, Liu J, Liu HB, )90.2(Y)99.8(e M, Zhang )90.1(YF)79.8(, )90.2(Y)99.8(ang)5( )]TJ
0.15 Tw 0 -1.176 TD
[(DS. )54.9(Abnormal CO)39.8(X2 protein e)14.9(xpression may be)5( )]TJ
0.189 Tw T*
[(correlated with poor prognosis in oral cancer: a)5( )]TJ
-0.003 Tc -0.075 Tw T*
(meta-analysis. Biomed Res Int. 2014; 2014: 364207.)Tj
0.005 Tc 0.026 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(19.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Chen )0.5(JL, )0.5(Huang )0.5(CY)128.9(, )0.5(Huang )90.3(YS, )]TJ
/T1_1 1 Tf
13.439 0 Td
[(et )0.5(al)]TJ
/T1_0 1 Tf
[(. Dif)24.9(ferential)5( )]TJ
0.014 Tc 0.3 Tw -13.439 -1.176 Td
[(c)0.5(li)0.5(n)0.5(ic)0.5(al)0.5( )0.5(ch)0.5(a)0.5(ra)0.5(c)0.5(te)0.5(r)0.5(is)0.5(t)0.5(ic)0.5(s,)0.5( )0.5(tr)0.5(e)0.5(at)0.5(me)0.5(n)0.5(t )0.5(re)0.5(s)0.5(po)0.5(n)0.5(se)0.5( a)0.5(n)0.5(d)14( )]TJ
0.006 Tc T*
[(pr)0.5(og)0.5(nos)0.5(is )0.5(of )0.5(lo)0.5(ca)0.5(lly)0.5( a)0.5(dv)25.3(a)0.5(nc)0.5(ed)0.5( ad)0.5(en)0.5(oca)0.5(rc)0.5(in)0.5(oma)0.5(/)]TJ
-0.003 Tc -0.075 Tw T*
(adenosquamous carcinoma and squamous cell carci)Tj
0 Tc 0 Tw (-)Tj
0.005 Tc -0.05 Tw T*
[(noma of cervix treated with de\037niti)25(v)14.8(e radiotherap)9.8(y)64.9(.)5( )]TJ
0.05 Tw 0 -1.176 TD
(Acta Obstet Gynecol Scand. 2014; 93: 661-8.)Tj
0.026 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(20.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Lee )90.2(YY)128.9(, Choi CH, Kim )18.3(TJ, )]TJ
/T1_1 1 Tf
(et al)Tj
/T1_0 1 Tf
[(. )55.3(A comparison of)5( )]TJ
-0.075 Tw 0 -1.176 TD
[(pure adenocarcinoma and squamous cell carcinoma)5( )]TJ
0.165 Tw T*
[(of the cervix after radical h)4.9(ysterectomy in stage)5( )]TJ
0.05 Tw T*
(IB-IIA. Gynecol Oncol. 2011; 120: 439-43.)Tj
0.009 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(21.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Nogueira-Rodrigues )55(A, Ferreira CG, Ber)17.9(gmann )55(A,)5( )]TJ
-0.052 Tw T*
[(de )54.8(Aguiar SS, )17.6(Thuler LC. Comparison of adenocar)]TJ
0 Tc 0 Tw 20.138 0 Td
(-)Tj
0.003 Tc -0.075 Tw -20.138 -1.176 Td
[(cinoma \(A)39.9(CA\) and squamous cell carcinoma \(SCC\))3( )]TJ
0.005 Tc 0.125 Tw T*
[(of the uterine cervix in a sub-optimally screened)5( )]TJ
0.019 Tw T*
[(cohort: a population-based epidemiologic study of)5( )]TJ
0.207 Tw T*
[(51,842 )0.5(w)9.7(omen in Brazil. Gynecol Oncol. 2014;)5( )]TJ
0.05 Tw T*
(135: 292-6.)Tj
0.098 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(22.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Dursun P)110.8(, )89.7(Y)110.8(uce K, Usub)19.8(utun )54.8(A, )54.7(A)91.8(yhan )54.7(A. Cyclo)]TJ
0 Tc 0 Tw (-)Tj
0.005 Tc 0.103 Tw T*
[(oxygenase-2 e)14.9(xpression in cervical intraepithelial)5( )]TJ
0.004 Tc -0.075 Tw T*
[(n)0.5(eo)0.5(p)0.5(la)0.5(s)0.5(ia)0.5( )0.5(II)0.5(I)0.5( a)0.5(n)0.5(d )0.5(s)0.5(qu)0.5(a)0.5(mo)0.5(us)0.5( )0.5(ce)0.5(l)0.5(l )0.5(c)0.5(er)0.5(v)0.5(ic)0.5(a)0.5(l )0.5(c)0.5(a)0.5(rc)0.5(i)0.5(no)0.5(m)0.5(a,)4( )]TJ
0.005 Tc -0.063 Tw T*
[(and )0.5(its )0.5(correlation with clinicopathologic v)25(ariables.)5( )]TJ
0.05 Tw T*
[(Int J Gynecol Cancer)55(. 2007; 17: 164-73.)]TJ
0.248 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(23.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Kim )89.4(YB, Kim GE, Pyo HR, )]TJ
/T1_1 1 Tf
(et al)Tj
/T1_0 1 Tf
[(. Dif)24.9(ferential)5( )]TJ
-0.048 Tw T*
[(c)14.9(yclooxygenase-2 )0.5(e)14.9(xpression )0.5(in )0.5(squamous )0.5(cell )0.5(car)]TJ
0 Tc 0 Tw 20.138 0 Td
(-)Tj
0.005 Tc 0.036 Tw -20.138 -1.176 Td
[(cinoma and adenocarcinoma of the uterine cervix.)5( )]TJ
0.05 Tw T*
[(Int J Radiat Oncol Biol Ph)4.9(ys. 2004; 60: 822-9.)]TJ
0.047 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(24.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Sales KJ, Katz )55.2(AA, Da)19.8(vis M, )]TJ
/T1_1 1 Tf
(et al)Tj
/T1_0 1 Tf
(. Cyclooxygen)Tj
0 Tc 0 Tw (-)Tj
0.005 Tc 0.055 Tw T*
[(ase-2 e)15(xpression and prostaglandin E\(2\) synthesis)5( )]TJ
0.232 Tw T*
[(are up-re)14.9(gulated in carcinomas of the cervix: a)5( )]TJ
-0.003 Tc -0.075 Tw T*
[(possible autocrine/paracrine re)14.9(gulation of neoplastic)-3( )]TJ
0.005 Tc 0.057 Tw T*
(cell function via EP2/EP4 receptors. J Clin Endo)Tj
0 Tc 0 Tw (-)Tj
0.005 Tc 0.05 Tw T*
[(crinol Metab)39.8(. 2001; 86: 2243-9.)]TJ
0.034 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(25.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Lee JS, Choi )90(YD, Lee JH, )]TJ
/T1_1 1 Tf
(et al)Tj
/T1_0 1 Tf
[(. Expression of c)14.9(y)]TJ
0 Tc 0 Tw (-)Tj
0.005 Tc 0.032 Tw T*
[(clooxygenase-2 in adenocarcinomas )0.5(of the )0.5(uterine)5( )]TJ
0.109 Tw T*
[(cervix and its relation to angiogenesis and tumor)5( )]TJ
0.05 Tw T*
[(gro)24.9(wth. Gynecol Oncol. 2004; 95: 523-9.)]TJ
0.073 Tc -0.176 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
[(2)68(6)68(.)]TJ
/Span<>> BDC
1.412 0 Td
( )Tj
EMC
0.706 0 Td
[(B)0.5(a)0.5(l)0.5(a)0.5(n)0.5( )-495.5(R)0.5(,)0.5( )-440.5(A)0.5(m)]TJ
/C2_0 1 Tf
0 Tc 0 Tw 6.633 0 Td
<0103>Tj
/T1_0 1 Tf
0.073 Tc 0.32 Tw 0.516 0 Td
[(l)0.5(i)0.5(n)0.5(e)0.5(i)0.5( )0.5(C)0.5(,)0.5( )0.5(G)0.5(i)0.5(u)]TJ
0 Tc 0 Tw 6.205 0.004 Td
(s)Tj
0.056 -0.113 Td
(\202)Tj
0.425 0.109 Td
(c)Tj
/C2_0 1 Tf
0.073 Tc -0.073 Tw 0.516 0 Td
[<0103>0.7<0003>]TJ
/T1_0 1 Tf
1.159 0 Td
[(S)0.5(E)0.5(,)0.5( )]TJ
/T1_1 1 Tf
0.32 Tw 2.277 0 Td
[(e)0.5(t)0.5( )0.5(a)0.5(l)]TJ
/T1_0 1 Tf
0 Tc 0 Tw 2.432 0 Td
(. )Tj
0.053 Tc 0.3 Tw -20.221 -1.176 Td
[(Immunohistochemical e)24.7(v)24.7(aluation of CO)39.6(X-2)53( )]TJ
0.016 Tc T*
[(e)14.5(xpression in HPV)99.5(-positi)24.5(v)14.5(e cervical squamous)16( )]TJ
0.005 Tc 0.165 Tw 0 -1.176 TD
[(intraepithelial lesions. Rom J Morphol Embryol.)5( )]TJ
0.05 Tw 0 -1.176 TD
(2011; 52: 39-43.)Tj
0.245 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(27.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Czachoro)24.6(wski )-55.2(MJ, Amaral AF)79.6(, )-55.3(Montes-Moreno)5( )]TJ
-0.005 Tw T*
(S, )Tj
/T1_1 1 Tf
0.116 Tw 1.187 0 Td
(et al)Tj
/T1_0 1 Tf
[(. Cyclooxygenase-2 e)14.9(xpression in bladder)5( )]TJ
0.079 Tw -1.187 -1.176 Td
[(cancer and patient prognosis: results from a lar)17.8(ge)5( )]TJ
-0.064 Tw T*
[(clinical cohort and meta-analysis. PLoS One. 2012;)5( )]TJ
0.05 Tw T*
(7: e45025.)Tj
0.116 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(28.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Hassan )-55.1(HE, )-55.1(Mohamed AA, )-55.1(Bakhiet A)55(O, Ahmed)5( )]TJ
0.24 Tw T*
[(HG. Immunohistochemical e)14.9(xpression of CO)39.8(X2)5( )]TJ
-0.062 Tw T*
[(and iNOS in bladder cancer and its association with)5( )]TJ
0.066 Tw T*
[(urinary schistosomiasis among Sudanese patients.)5( )]TJ
0.05 Tw T*
[(Infect )54.9(Agent Cancer)54.9(. 2013; 8: 9.)]TJ
0.069 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(29.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Nag)4.9(ai N, )17.5(T)35(ian X, Mukai K, )]TJ
/T1_1 1 Tf
(et al)Tj
/T1_0 1 Tf
[(. Ov)14.9(ere)15(xpression)5( )]TJ
0.201 Tw T*
[(of c)14.9(yclooxygenase-2 protein and its relationship)5( )]TJ
0.263 Tw T*
[(to apoptosis in cervical carcinoma treated with)5( )]TJ
0.086 Tw T*
[(neoadjuv)24.9(ant chemotherap)9.8(y)64.9(. Int J Mol Med. 2003;)5( )]TJ
0.05 Tw T*
(12: 709-14.)Tj
0.037 Tc 0.3 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
[(3)32(0)32(.)]TJ
/Span<>> BDC
1.265 0 Td
( )Tj
EMC
0.706 0 Td
[(Landen CN Jr)39.8(, Mathur SP)110.9(, Richardson MS,)37( )]TJ
0.005 Tc 0.27 Tw T*
[(Creasman )30.2(WT)74(. Expression of c)14.9(yclooxygenase-2)5( )]TJ
-0.036 Tw T*
[(in cervical, endometrial, and o)14.9(v)24.9(arian malignancies.)5( )]TJ
0.05 Tw T*
(Am J Obstet Gynecol. 2003; 188: 1174-6.)Tj
0.01 Tc 0.3 Tw /Span<>> BDC
22.518 74.093 Td
( )Tj
EMC
0.147 0 Td
[(3)5(1)5(.)]TJ
/Span<>> BDC
1.265 0 Td
( )Tj
EMC
0.706 0 Td
[(Hammes LS, )18(T)70.1(ekmal RR, Naud P)111.1(, )]TJ
/T1_1 1 Tf
(et al)Tj
/T1_0 1 Tf
(. Up-)Tj
0.005 Tc 0.042 Tw T*
[(re)14.9(gulation of )49.5(VEGF)79.8(, c-fms and CO)39.8(X-2 e)14.9(xpression)5( )]TJ
-0.075 Tw T*
[(correlates with se)25.2(v)15.2(erity of cervical cancer precursor)5( )]TJ
-0.055 Tw T*
[(\(CIN\) lesions and in)39.8(v)24.9(asi)24.9(v)14.9(e )0.5(disease. Gynecol Oncol.)5( )]TJ
0.05 Tw T*
(2008; 110: 445-51.)Tj
-0.008 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(32.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Bandyopadh)4.9(yay R, Chatterjee U, Mondal SK, Nag)5.1( )]TJ
0.221 Tw T*
[(D, Sinha SK. )55.1(A study on e)14.9(xpression pattern of)5( )]TJ
0.141 Tw T*
[(c)14.9(yclooxygenase-2 in carcinoma of cervix. Indian)5( )]TJ
0.05 Tw T*
[(J P)14.9(athol Microbiol. 2011; 54: 695-9.)]TJ
0.115 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(33.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Gadducci )55.3(A, Guerrieri ME, Greco C. )18.2(T)34.9(issue bio)]TJ
0 Tc 0 Tw (-)Tj
0.005 Tc 0.011 Tw T*
[(mark)9.8(ers as prognostic v)24.9(ariables of cervical cancer)55(.)5( )]TJ
0.05 Tw T*
[(Crit Re)24.9(v Oncol Hematol. 2013; 86: 104-29.)]TJ
0.003 Tc -0.075 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
[(3)-2(4)-2(.)]TJ
/Span<>> BDC
1.265 0 Td
( )Tj
EMC
0.706 0 Td
[(Des)0.5(hpande R, M)0.5(ansara)0.5( P)111.2(, Ka)0.5(ul-Ghanek)0.5(ar R. )55.3(A)0.5(lpha-)]TJ
0.005 Tc 0.108 Tw T*
[(linolenic acid re)14.9(gulates Cox2/VEGF/MAP kinase)5( )]TJ
0.298 Tw T*
[(pathw)9.8(ay and decreases the e)14.9(xpression of HPV)5( )]TJ
-0.017 Tw T*
[(oncoproteins E6/E7 through restoration of p53 and)5.1( )]TJ
0.027 Tw 0 -1.176 TD
[(Rb e)14.9(xpression in human cervical cancer cell lines.)5( )]TJ
0.05 Tw 0 -1.176 TD
[(T)44.9(umour Biol. 2016; 37: 3295-305.)]TJ
0.151 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(35.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
(Li B, Li X, Xiong H, )Tj
/T1_1 1 Tf
(et al)Tj
/T1_0 1 Tf
[(. Inhibition of CO)39.8(X2)5( )]TJ
-0.075 Tw T*
[(enhances the chemosensiti)25.2(vity of dichloroacetate in)5( )]TJ
-0.005 Tc T*
[(cervical cancer cells. Oncotar)17.6(get. 2017; 8: 51748-57.)]TJ
0 Tc 0 Tw -2.118 -1.176 Td
( )Tj
/T1_2 1 Tf
12 0 0 12 275.4 424.3445 Tm
( )Tj
ET
endstream
endobj
24 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
BT
0 0 0 1 k
/GS0 gs
/T1_0 1 Tf
0.005 Tc 0.05 Tw 0 Ts 100 Tz 0 Tr 9.5 0 0 9.5 344.9443 721.5615 Tm
[(CO)39.8(X2 IN CER)17.9(VICAL CANCER)]TJ
ET
endstream
endobj
29 0 obj
<>
endobj
30 0 obj
<>
endobj
31 0 obj
<>stream
H\Mj0:,Ec!an^=-SA-Y^I!
On=w7=(8MAicg'q5gV7isWn?8AUtxE}in|!}2#'$ܐVJbhԿ>HyeT(TxGB\$.ħu:%%51e_!!11;)ax"(16x);Y UW /,
endstream
endobj
32 0 obj
<>stream
HdSkLSg>rN1Hqbӣ ަ:\`JE"*UhK[.P^P6EEa-:QE-%Ƙ__K=D` A䢽)ݶ:C]2I1敪eHA@Qx.{a!kC@
kӋ)BbfΤW+7މݏ^a⸤Bmm2Ue.ESwᜲٗS
+D`֥ pqzyq!z0#,{mt,/1b/azzwluf :;[rU8SQz=06!&w}ECu9ր㛂35jE;[+WYCM
I+Z,Sscp` (+J/=ou0&VdYz'>%x/9F]zVS86]'Qg=ʮIg.m]J'.Xy9cLMczSN#+ys/"^Wa
![j\_0g۔AKj$}Q2?94'rxV\5>ӁxFȂFzOc=s"9VA.@'oF_눗:;]56fDy?{Zh<` '
,nlMYmTKS4d:w{T7g)XA=|=rX -nRZI<[}Ǜ.8467g߶ˍAyFۏ:h%
I'QvSSoxSu;1Ɗc1SӷUj+t6Q|F>%8&3l/(Mu,H{f~%3
xcQt05>aM2ta`_ O
endstream
endobj
13 0 obj
<>
endobj
28 0 obj
<>
endobj
15 0 obj
<>
endobj
19 0 obj
<>
endobj
16 0 obj
<>
endobj
40 0 obj
<>
endobj
41 0 obj
<>
endobj
42 0 obj
<>stream
H\n0E~
/EşRRmG H
,: a_vnW_a%t^qUQ~SvvVYڎIյ~Ǘ%\ݪ^eazweɏub[;'4ar}ss.sAnyn;Uǣk<r}Ak"|jT]9"?O4fCD8 \+r6dd^W`W74444444444B#;0{2e